Proposition 38: The California Immunology Research & Cures Initiative

Proposition 38: Authorizes Bonds For Immunology Medical Research. Initiative Statute


Additional Titles

The California Immunology Research & Cures Initiative

Immunology and Immunotherapy Research Funding Initiative

Summary

Proposition 38 began as a citizen-initiated state statute filed with the California Attorney General’s Office who cleared the initiative for signature gathering on January 2, 2026. To qualify for the ballot, proponents were required to collect 546,651 valid signatures. On June 23, 2026, the Secretary of State announced that the campaign collected enough signatures that the initiative qualified for the November 2026 ballot as Proposition 38. 

Proposition 38 authorizes California to issue an $8.4 billion general obligation bond to fund medical research in immunology and immunotherapy, with state payments taken from the state General Fund. The measure mandates that at least $4.2 billion be dedicated specifically to research on cancer, heart disease, and Alzheimer’s disease, while capping state administrative expenditures at 2 percent. The bond proceeds are divided equally between a designated specialized research institute selected by the California Department of Public Health that meets specific size, funding, and University of California (UC) collaboration criteria, while the remaining half is distributed as competitive research grants to California universities and non-profit research institutions via an advisory council.

Proposition 38 mandates that the institute generate as much revenue as possible from the funded research. Ten percent of this revenue would go to the state’s General Fund until the research bond is repaid. Additional funding would be used for future immunotherapy and immunology research. Grant recipients are required to purchase at least half of their goods and services from California suppliers whenever feasible, and any treatments developed through this research and sold within California must generally be offered to patients at a 20 percent discount. Both the designated institute and the grant council are subject to annual public reporting and independent financial audit requirements. Both the designated institute and the grant council are subject to annual public reporting and independent financial audit requirements.

Fiscal Impact

(Summary of Legislative Analyst's Estimate of Net State and Local Government Fiscal Impact)

If Proposition 38 passes, the state General Fund would incur an estimated annual repayment cost of $500 million to $600 million over roughly 20 years to pay off the bond. This would amount to about 0.25% of the state's total General Fund budget and approximately 10% more total cost (adjusted for inflation) than upfront funding due to interest. Offsetting these expenditures, the state could potentially earn significant revenue from commercialized research treatments funded by the measure, though the amount and timing remain uncertain and could take decades to materialize. Additionally, the initiative would generate indirect fiscal effects on state health programs like Medi-Cal, where net costs could rise or fall depending on the pricing and adoption of newly developed medical treatments.

What your vote means

YES: A YES vote supports issuing $8.4 billion in state general obligation bonds for immunology and immunotherapy research, allocating half of the funds to a University of California-affiliated research institute and distributing the remainder as grants to California public and nonprofit medical research institutions.

NO: A NO vote opposes issuing $8.4 billion in state bonds to fund immunology and immunotherapy research and treatment development.

Official Voter Information

Non-partisan Voter Information

Public Opinion Polls

Pro/Con Statements

ProCon

Proponents believe that The California Immunology Research & Cures Initiative aims to accelerate lifesaving medical breakthroughs by investing in immunotherapies that empower the patient's own immune system to target and combat disease. Supporters emphasize that because these therapies are already effectively treating certain cancers and chronic conditions, dedicated state funding will help move proven, cutting-edge science out of the research lab and into clinical treatments for patients more quickly. 

The opposition argues that Proposition 38 is a deceptive measure designed to benefit its billionaire donor by funneling state resources toward a single institution using arbitrary criteria. Opponents contend that state funds for medical research should instead be allocated through a fair, competitive process where all eligible applicants have an equal opportunity to compete.

SupportersOpponents
  • Yes on 38
  • Michael J. Fox Foundation
  • Alzheimer’s Los Angeles
  • Kidney Cancer Association
  • American Nurses Association, CA
  • American Association of Immunologists
  • California Democratic Party
  • City of Hope
  • Michelson Center for Public Policy

See the Proposition Ballot Endorsement Table for additional supporters and opponents.

Certified Results

YesNo
Total Votes:Total Votes:
Percent of Vote:Percent of Vote:
Source: California Secretary of State. Election Results, Statement of Vote.